NICU Antibiotics and Outcomes (NANO) Follow-up Study

ClinicalTrials.gov ID: NCT05977400

Public ClinicalTrials.gov record NCT05977400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

NICU Antibiotics and Outcomes Follow-Up Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The NANO follow-up study is designed to determine whether a simple, cost-effective intervention- withholding antibiotics at birth- reduces clinically relevant outcomes such as behavioral and neurological impairment at 2 years of age. This study will be the largest study evaluating the effects of early antibiotics in children with comprehensive measures of neurodevelopment linked to genomic variants and microbiota interactions.

Study identification

NCT ID: NCT05977400
Recruitment status: Not yet recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Sharp HealthCare; Other
Enrollment: 802 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 23 Weeks to 30 Weeks
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2024 (Estimated)
Primary completion: Mar 2029 (Estimated)
Completion: Mar 2029 (Estimated)
Last update posted: Aug 4, 2023

2024 – 2029

United States locations

U.S. sites: 14
U.S. states: 7
U.S. cities: 12

Facility	City	State	ZIP	Site status
Sharp Mary Birch Hospital for Women & Newborns	San Diego	California	92123	—
Yale University	New Haven	Connecticut	06511	—
University of South Florida	Tampa	Florida	33620	—
University of Louisville	Louisville	Kentucky	40292	—
State University of New York Downstate	Brooklyn	New York	11203	—
Columbia University	New York	New York	10027	—
University of Rochester	Rochester	New York	14611	—
Westchester Medical Center	Valhalla	New York	10595	—
The Pennsylvania State University	Hershey	Pennsylvania	17033-0850	—
The Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	—
Jefferson Medical College of Thomas Jefferson University	Philadelphia	Pennsylvania	19107	—
Magee-Womens Hospital	Pittsburgh	Pennsylvania	15213	—
The University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
University of Texas Health Science Center at San Antonio	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05977400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 4, 2023 · Synced Oct 24, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05977400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →